MediWound begins pivotal Phase III trial for wound therapy
YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
MediWound Ltd.: MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
MediWound to launch Phase III trial for venous leg ulcers
MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.
Science Daily12h
New smart sensor takes the pain out of wound monitoring
A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they occur at the same time. Researchers addressed this issue by uncovering a new ...
BestReviews on MSN18h
The best skin care products to combat dry skin in winter
Heating your home feels great, but it can dry the air and your skin. Excessive bathing: Bathing too often can strip your skin ...
Le Lézard23h
HYDRINITY Accelerated Skin Science Expands into United Kingdom and Ireland
HYDRINITY Accelerated Skin Science, the fastest growing professional medical skincare brand in the US, is proud to announce their new partnership with Unique Skin, a leading name in advanced ...